Showing results (1281-1290 of 1,325) with videos related to

Sort By:
Pageof 133
Revue Medicale Suisse|December 7, 2017
[Rare vascular diseases, building dedicated multidisciplinary specialized center]Caroline Krieger, David Baud, Judith Bouchardy, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Gut microbiome-dependent IL-1 signaling is a mediator of ACVR1 <sup>R206H</sup> -driven heterotopic ossificationHannah M Herzog, Camille Fang, Liam Lam, et al.
Human Genetics|September 12, 2000
Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13M Takahashi, E Rapley, P J Biggs, et al.
Circulation|July 1, 2021
Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney DiseaseStefan J Schunk, Sarah Triem, David Schmit, et al.
Cancer Discovery|June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapyHikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Bioactive Materials|February 24, 2026
Glycosaminoglycan-functionalized hydrogels for sustained delivery of tissue inhibitor of metalloproteinase-3 mediating matrix metalloprotease inhibition and extracellular matrix stabilizationFabian Junker, Stefan Rupf, Paula Marie Schindler, et al.
Nature|November 26, 2020
The gut microbiota is associated with immune cell dynamics in humansJonas Schluter, Jonathan U Peled, Bradford P Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2019
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed GlioblastomaBryan G Allen, Kellie L Bodeker, Mark C Smith, et al.
Circulation|October 14, 2021
Loss of Mitochondrial Ca<sup>2+</sup> Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome CardiomyopathyEdoardo Bertero, Alexander Nickel, Michael Kohlhaas, et al.
BMJ (Clinical Research Ed.)|November 11, 2025
Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trialIan G Stiell, Monica Taljaard, Debra Eagles, et al.
Pageof 133